O. V. Shevchuk

O. V. Shevchuk

Auto-generated profile, based on publicly available information

O. V. Shevchuk

National Pirogov Memorial Medical University

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2025 in Rheumatology
Verified
Journal Article
Open access
SSSergii Shevchuk
Sergii Shevchuk
OPOksana Pavliuk
Oksana Pavliuk
OSOlena Shevchuk
Olena Shevchuk
Introduction: The aim was to assess osteocalcin (OC) and N-terminal telopeptide of type I collagen (NTx) levels in men with ankylosing spondylitis (AS) and evaluate their relationship with the course of the disease and the structural and functional state of bone tissue.Material and methods: The study was conducted on 83 male patients with AS and 29 healthy individuals constituting the control group. Disease activity and functional limitations were assessed using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Ankylosing Spondyloarthritis Disease Activity Score with C-reactive protein (ASDAS-CRP), and Bath Ankylosing Spondylitis Functional Index (BASFI) functional indices. Laboratory testing included CRP and markers of bone synthesis and resorption. Bone mineral density (BMD) of the lumbar spine and femoral neck was determined using dual-energy X-ray absorptiometry.Results: The mean OC levels did not differ significantly between AS patients and the control group and showed no significant correlation with ASDAS, BASDAI, BASFI and CRP indices. On the other hand, NTx values were significantly higher in AS patients than in the control group (105.8 ±3.4 ng/ml vs. 92.6 ±5.1 ng/ml) and were closely related to the activity of the inflammatory process and low functional capacity. The structural and functional state of the bone is impaired by increased bone resorption. Thus, the proportion of patients with low BMD and fractures (68.2% and 27.3%) in the group of patients with high NTx content was 4–12 times higher than with optimal levels of this marker (17.7% and 2.2%). On the other hand, osteoproliferative changes were not associated with NTx levels but were dependent on serum OC levels. In particular, in the group of patients with syndesmophytes, serum OC values were higher (by 12.4%) than in the group without syndesmophytes.Conclusions: Elevated NTx levels are associated with high inflammatory activity and low BMD. On the other hand, OC concentration is not associated with disease progression but is increased in individuals with syndesmophytes.

17 February 2018 in Regulatory Mechanisms in Biosystems
Verified
Journal Article
Open access
PDF file
SSS. V. Shevchuk
S. V. Shevchuk
YSY. S. Seheda
Y. S. Seheda
OGO. Y. Galyutina
O. Y. Galyutina
NMN. P. Masik
N. P. Masik
OSO. V. Shevchuk
O. V. Shevchuk
Nowadays low paraoxonase activity is generally recognized as an independent risk factor of cardiovascular diseases involved in pathologic remodeling of the heart and vessels as well as thrombosis in the general population. But the role of paraoxonase activity in RA patients is unknown. Based on the above, the aim of the work was to study serum paraoxonase activity in patients with rheumatoid arthritis, to evaluate its association with clinical course and structural and functional status of the cardiovascular system. 67 patients with RA, 18 males and 49 females were studied. The control group consisted of 25 apparently healthy individuals. Rheumatoid arthritis was diagnosed according to international classification criteria ACR 2012. The indices of total cholesterol (TC), high density lipoprotein cholesterol (HDLC) and triglycerides (TG) in blood serum were determined by standard conventional methods. Low density lipoprotein cholesterol (LDLC) values were calculated by Friedwald formula. Serum paraoxonase activity was measured by spectrophotometric method. High resolution ultrasound and Doppler ultrasonography of the brachial artery were performed to study endothelium function. Sonographic B-mode scanning and pulsed Doppler ultrasound of heart and blood flow spectra were done on ultrasound scanner. Serum paraoxonase activity was found to be about 18.8% lower in the patients with RA than in the control group. Serum paraoxonase activity was shown to decrease proportionally to the increase of the age in RA patients. In the group of patients over 45, the level of the enzyme was 13.0% lower than in the patients over 30. The study established that the increase of systolic and diastolic arterial pressure is associated with decrease of serum paraoxonase activity in RA patients. The patients with RA combined with arterial hypertension had significantly (by 10.9%) lower activity of the studied enzyme than those with no arterial hypertension. However, no significant relationship between paraoxonase activity and duration of the disease, obesity and smoking was revealed. Paraoxonase activity in RA patients was demonstrated to be dependent on lipid levels. The lowest paraoxonase activity was recorded in individuals with the highest levels of TC, LDLC and the lowest HDLC indices. Paraoxonase activity in RA patients is associated not only with atherosclerotic vascular damage (IMT, decreased FMDBA) but also with structural and functional heart status (systolic and diastolic functions, left ventricular myocardial hypertrophy). Decreased serum paraoxonase level is suggested to be the predictor of early development of cardiovascular complications in RA patients.

17 March 2011 in Rheumatology
Verified
Journal Article
Open access
PDF file
SSSergii Shevchuk
Sergii Shevchuk
ISIuliia Segeda
Iuliia Segeda
IKI. Kuvikova
I. Kuvikova
OSO. Shevchuk
O. Shevchuk
SSS. Segeda
S. Segeda
CGC. Gordon
C. Gordon
Background: Patients with SLE are known to have early development of atherosclerotic process. However pathogenic mechanisms of accelerated atherogenesis is not completely detected in patients with SLE, though we think that chronic inflammatory process changes endothelium status and contributes to vascular impairment. Antiphospholipid syndrome (APS) is one of the most important causes of thrombosis in SLE. In addition, recent research indicates association of cardiovascular complications with hyperhomocysteinemia. The aim of this study was to investigate the association of thrombosis with plasma total homocysteine (ptHcy), dyslipidemia, antiphospholipid antibodies (aPL) and other vascular risk factors in SLE patients. Methods: 53 patients with SLE mean age 31,6 ± 6,8 years and 31 healthy persons age and sex-matched were examined. Mean duration of disease was 65 ± 4 months. Clinical and immunological data were obtained from our prospective computerized database. aPL-positivity was defined according to Sapporo criteria. In all patients with SLE activity of disease was evaluated according to disease activity index (SLEDAI). The median SLE disease activity index (SLEDAI) was 16,2 ± 7,5. Results: There was no association between aPL and ptHcy and dyslipidemia. ptHcy was higher in patients with arterial (median 15.06 versus 11.12 micromol/L, P = 0.010) but not venous thrombosis. In the subgroup analysis, this association was only seen in aPL-negative patients. In logistic regression, aPL (OR 6.85, 95% CI 1.93-26.41) and ptHcy (OR 1.12, 95% CI 1.07-1.31) were independently associated with arterial thrombosis. However, when hypertension, smoking and plasma total cholesterol were added to the model, only aPL (OR 7.68, 95% CI 2.02-31.84) and hypertension (OR 7.83, 95% CI 3.25-28.44), but not ptHcy, remained independently related to arterial events. aPL was the only variable independently related to venous thrombosis (OR 7.76, 95% CI 1.70-34.46). ptHcy concentrations and total cholesterol are higher in SLE patients with arterial thrombosis. No interaction between homocysteine, total cholesterol and aPL was found. We believe that increased levels ptHcy and total cholesterol may be a marker of increased vascular risk in aPL-negative SLE patients. Conclusions: In this study we did not find association between aPL with hyperhomocysteinemia and dyslipidemia, although hyperhomocysteinemia and dyslipidemia correlated with disease activity index (SLEDAI). The role of homocysteine and dyslipidemia as a marker of vascular risk may depend on the presence of traditional risk factors, such as man sex, smoking and hypertension, although a modest intrinsic effect cannot be entirely excluded. Disclosure statement: The authors have declared no conflicts of interest.

28 February 2025 in Медична освіта
Verified
Journal Article
Open access
ОАО. І. Альчук
О. І. Альчук
ОШО. В. Шевчук
О. В. Шевчук
НВН. І. Волощук
Н. І. Волощук
Анотація. Глобальна діджиталізація, штучний інтелект, швидка еволюція технології передачі інформації, з одного боку, COVID-19 та велика повномасштабної агресія росії у 2022 р. – з іншого, поставили перед викладацьким складом ЗВО, зокрема перед колективом кафедри фармакології ВНМУ ім. М.І. Пирогова низку важливих завдань та проблем, які потрібно було вирішувати не лише ефективно, а й швидко. У роботі висвітлено наш досвід застосування сучасних дистанційних комунікаційно-цифрових технологій у поєднанні з новими методиками аудиторних занять. Описано методику дистанційних занять, які проводилися за допомогою сервісу MS Teams, що об'єднала всі навчальні ресурси нашого університету та дає змогу відстежити весь алгоритм роботи студента. Викладено особливості проведення проміжних заліків та екзамену в умовах дистанційного навчання. Проведений нами аналіз проблем, що виникали під час дистанційного навчання, з одного боку, та розуміння абсолютної невід’ємності online-інструментів у житті суспільства – з іншого, дали змогу випробувати та втілити в життя змішаний формат (blendetlearning) ведення практичних занять з акцентом на комунікативний та персоніфікований, особистісний підхід до студентів. Маючи в арсеналі багато цікавих, дієвих інформаційно-комунікативних технологій викладання, нашим першочерговим завданням стало привернути увагу та зацікавленість студентів до offline-занять. Ми прагнули підвищити мотивацію студентів і водночас максимально полегшити сам процес засвоєння вкрай складного предмету. Завдячуючи описаним у статті методикам викладачам кафедри вдалося привернути увагу студентів до аудиторного навчання, підвищити їхній інтерес та бажання вчитися, полегшити вивчення фармакології та максимально наблизити їх до практичної медицини. Підтвердженням цього є надзвичайно великий інтерес наших студентів до олімпіади з фармакології, зацікавленість у роботі наукового гуртка та чудово виконані студентські наукові роботи на щорічних студентських наукових конференціях.

2 February 2013 in Bukovinian Medical Herald
Verified
Journal Article
Open access
PDF file
SSS. V. Shevchuk
S. V. Shevchuk
YSYa. S. Seheda
Ya. S. Seheda
OSO. V. Shevchuk
O. V. Shevchuk
У результаті проведених досліджень продемонстровано значне зниження активності сироваткової параоксонази в українській популяції хворих на антифосфоліпідний синдром (АФС). Основними чинниками, які впливають на рівень ферменту, були чоловіча стать, вік, артеріальна гіпертензія, тютюнокуріння, порушення ліпідного обміну. Перебіг захворювання та ожиріння суттєвої ролі не відігравали. Встановлено причинно-наслідкові зв’язки низької ферментативної активності у хворих на АФС та наявності високих титрів антитіл до кардіоліпіну та β2-глікопротеїну-1. Зниження рівня параоксанази є предиктором раннього розвитку структурно-функціональних змін у судинах хворих на АФС.

1 June 2017 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
ISI Segeda
I Segeda
SSS Shevchuk
S Shevchuk
IKI Kuvikova
I Kuvikova
OSO Shevchuk
O Shevchuk
Background Cobalamin (vitamin B12) insufficienty is associated with the development of many diseases. It is known that the growth of clinical and subclinical manifestations of atherosclerotic vascular lesions are often associated with low cobalamin level. Cobalamin status is unknown in patients with antiphospholipid syndrome (APS). There are no data about the role of folic acid in the development of atherosclerotic vascular lesions in patients with APS Objectives To evaluate vitamin B12 status in patients with APS and to explore its relationship with atherosclerotic vascular lesion. Methods We observed 82 patients with APS and 37 healthy individuals. Content of cobalamin (vitamin B12) in serum were determined by immunochemical detection (ECLIA). Cobalamin level above 200 pg/ml was considered as normal within 200–300 pg/mL - both extremely low, below 200 pg/ml - insufficienty. All patients were underwent detection of endothelial dysfunction - dilatation of brachial artery endothelium, investigation of “intima-media” thickness of common carotid artery (IMT) and the presence of atherosclerotic plaques (AP). Results In patients with APS we recorded a significant reduction of cobalamin in the serum (351±14,3 pg/mL (95% CI: 148–562 pg/mL) compared to control group (445±18,1 pg/mL (95% CI: 272–622 pg/mL). Indicators of cobalamin status in patients with secondary APS were significantly worse than patients with primary APS. Thus, in patients with secondary APS cobalamin content was on 26.7% lower (95% CI: 140–559 pg/ml) than in the control group. In patients with primary APS cobalamin content was on 13.0% lower (95% CI: 202–565 pg/ml) than in controls, but 18.7% higher than in patients with secondary APS. Cobalamin (vitamin B12) insufficienty is accompanied by significant thickening of the walls of the common carotid artery. Thus, in patients with cobalamin deficiency IMT was on 17% higher than that in patients with optimal levels of the vitamin. Cobalamin deficiency is also associated with endothelial dysfunction. Thus, in patients with vitamin deficiency dilatation of brachial artery was significantly, by 48.6% less than in people with normal vitamin B12 status. The share of people with the presence of atherosclerotic plaques, transient ischemic attack (TIA), stroke, myocardial infarction (MI) and angina in patients with cobalamin deficiency was also higher. Conclusions Thus, in patients with APS low cobalamin status is associated with subclinical manifestations of atherosclerotic vascular lesions. Disclosure of Interest None declared